The rapid advancement of Artificial Intelligence (AI) has highlighted the need to develop regulatory and ethical parameters for its use. In this context, the university needs to position itself as a protagonist and co-responsible for this process. This study describes the process of constructing a Policy for the Use of Artificial Intelligence in a Higher Education Institution (HEI) located in the city of Curitiba, Paraná. This is a combined, applied, and descriptive study, articulating field research and experience reporting, carried out in six stages and involving 79 participants in the data collection phase. The study highlighted the complexity of the topic, involving aspects related to principles, governance, and applications in teaching, research, outreach, and management. The development of the Policy allowed for a deeper understanding of the ethical and responsible use of AI, creating clearer outlines for its application, as well as enabling further reflection on the future of education.
INTRODUCTION:The Brazilian Society of Surgical Oncology (SBCO) developed national guidelines for the rational use of blood concentrates in surgical procedures. METHODS:Between June and December 2024, a multidisciplinary team of 42 experts formulated 48 key questions on the rational use of blood concentrates in surgery. The guidelines were structured in three phases: preoperative, intraoperative, and postoperative. Expert groups performed literature reviews and proposed preliminary recommendations, which were later refined by the coordinators. An adapted grading system was used to assess the level of evidence, and an online voting process determined consensus among experts. CONCLUSION:Implementing a bloodless surgery protocol requires a meticulous and coordinated approach across multiple medical disciplines. Essential elements for success include patient and staff education, comprehensive preparation, and the use of advanced surgical techniques and technologies to optimize outcomes.
Despite apparent cure after treatment of localized prostate cancer (PC), a significant proportion of patients who undergo radical prostatectomy (RP) or radiotherapy (RT) will experience biochemical recurrence (BCR) within 10 years. This study was conducted to evaluate the main aspects of BCR after primary definitive treatment in a real-world setting in Brazil. In this retrospective, single-center, observational cohort study, data were extracted from electronic medical records of patients aged ≥18 years with PC, treated at one clinical site in Brazil, who underwent definitive curative-intent treatment during January 1, 2005–December 31, 2018. The primary objective was to estimate 5-year BCR rate, defined per European Association of Urology (EAU) criteria as PSA >0.2 ng/mL after RP, or PSA nadir + 2 ng/mL above nadir after RT. Of 971 patients included, 131 (13.5
IntroductionGiven the high disparities present in cancer care worldwide and even more challenging infrastructure and access for low- and middle-income countries, adhering precisely to international guidelines has become a challenging and complex task. Recommendations from an independent multidisciplinary panel of experts from 13 countries, including medical oncologists, pathologists, surgeons, and radiation oncologists, who met during IGCS to address some of these challenges.MethodsThe panel met in New York City in September of 2022 during the International Gynecological Cancer Society Congress and was composed of specialists from developing countries in Africa, Asia, Eastern Europe, Latin America, and the Middle East. The panel addressed 103 questions and provided recommendations for the management of early, locally advanced, recurrent, and/or metastatic endometrial cancer. The questions were carefully developed by the group and specifically directed to, and answered by, specialists according to their respective areas of expertise. Consensus was defined as at least 75% of the voting members selecting a particular recommendation, whereas a majority vote was considered when one option garnered between 50.0% and 74.9% of votes. Resource limitation was defined as any issues limiting access to qualified surgeons, contemporary imaging or radiation-oncology techniques, antineoplastic drugs, or funding for providing modern medical care.ResultsEighteen of the 109 (16.5%) questions presented to the panel reached consensus, whereas a majority vote was reached for 43 (39.4%) additional questions. The recommendations for the remaining questions were considerably heterogeneous and were considered experts opinion only.ConclusionEstablishing guidelines with recommendations in areas with resource limitations may help healthcare providers and improve patient care around the world.